Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Abstract Text:

Michael A Letavic,Emily M Stocking,Ann J Barbier,Pascal Bonaventure,Jamin D Boggs,Brian Lord,Kirsten L Miller,Sandy J Wilson,Nicholas I Carruthers,

The design, synthesis, and in vitro activity of a series of novel 5-ethynyl-2-aryloxybenzylamine-based histamine H(3) ligands that are also serotonin reuptake transporters is described.

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Publishing Authors By Initials

MA Letavic,EM Stocking,AJ Barbier,P Bonaventure,JD Boggs,B Lord,KL Miller,SJ Wilson,NI Carruthers,

For similar chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: neurotransmitter agents: neurotransmitter uptake inhibitors: serotonin uptake inhibitors research abstracts see: chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: neurotransmitter agents: neurotransmitter uptake inhibitors: serotonin uptake inhibitors research

PUBMED ID PMID:

MEDLINE DATE:

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Bioorganic & medicinal chemistry letters

VOLUME: 17

Page Numbers: 4799-803

Journal Abbreviation: Bioorg. Med. Chem. Lett.

ISSN: 0960-894X

DAY: 26

MONTH: 06

YEAR: 2007

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9107377

Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Keywords Mesh Terms:

KEYWORDS: Serotonin Uptake Inhibitors

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors. Information

Substance Name: Serotonin Uptake Inhibitors

Registry Number: 0

Grant and Affiliation Information for Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.

AFFILIATION: Johnson & Johnson Pharmaceutical Research & Development LLC, 3210 Merryfield Row, San Diego, CA 92121, USA. mletavic@prdus.jnj.com

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Bioorg Med Chem Lett

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Benzylamine histamine H3 antagonists and serotonin reuptake inhibitors Related Publications

• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
• A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion of the TgMIC2-M2AP invasion complex.
• A transient forward-targeting element for microneme-regulated secretion in Toxoplasma gondii.
• ATP-dependent sugar transport complexity in human erythrocytes.
• Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
• Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice.
• Caveat emptor (buyer beware).
• Discussion: the history of injectable silicone fluids for soft-tissue augmentation.
• Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
• Elderly patients with hypertension should retain 'special' status.
• Endocrine and superovulatory responses in heifers pretreated with FSH or bovine follicular fluid.
• Host cell manipulation by the human pathogen Toxoplasma gondii.
• Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
• Laboratory testing of spermicidal preparation.
• Lead identification of acetylcholinesterase inhibitors-histamine H(3) receptor antagonists from molecular modeling.
• MARveling at parasite invasion.
• Mad cows, prions, and wrinkles.
• Malakoplakia: report of a case.
• Patient-reported outcomes with botulinum neurotoxin type A.
• Recent medicinal chemistry of the histamine H3 receptor.
• Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.
• Shrinking upper and lower eyelid skin with a novel radiofrequency tip.
• Some points in the diagnosis of labyrinthine vertigo and a survey of methods of treatment, medical and surgical.
• Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
• The J-curve--it is clinically relevant?
• The diagnosis of late life hypogonadism.
• The evolution of botulinum neurotoxin type A for cosmetic applications.
• The organization of a community: community-based prevention of injecting drug use-related health problems.
• The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.
• [Not Available.]